If you have heard the buzz about these revolutionary treatments, you are certainly not alone
J Neural Transm 122:867872 Hota KB, Hota SK, Chaurasia OP, Singh SB (2012) Acetyl-l-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis
Alhemo, an anti-tissue factor pathway inhibitor given as a once-daily subcutaneous shot, raises levels of the bloodclotting protein thrombin
Since oxidation participates as an essential messenger of cellular signaling pathways, treatment of oxidative stress needs to consider maintaining that physiologic threshold (230, 231)
Semaglutide was not generally detected in urine samples except in one subject in the ESRD group (who had a very low urine volume) and therefore CL R was not assessed
Two additional trials, CREDENCE (Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy) (canagliflozin) and DAPA-HF (Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction) (dapagliflozin), evaluated alternative primary outcomes of renal events and HF events in patients with CKD stage 2/3 and chronic HF, respectively, and analyzed 3P-MACE as a secondary endpoint